Is a Cure for Blood Cancer Around the Corner?

hearing loss in PV
Study Identifies Factors Associated With Hearing Loss in Polycythemia Vera
September 21, 2016
MPN survey ET
Survey Seeking Essential Thrombocythemia Patients to Share Their Experiences
December 21, 2016

Is a Cure for Blood Cancer Around the Corner?

New Leukemia Research in Phase I/IIa Clinical Trial

Biosight, an Israeli pharmaceutical development company that is working on a cure for leukemia, this week closed an investment of $13 million led by pharmaceutical investment firm Arkin Holdings, run by pharma mogul Mori Arkin, and US-based venture firm Primera Capital. The money will be used to fund an advanced phase study of the company’s lead product, Astarabine, for the treatment of AML — acute myeloid leukemia, one of the two most common forms of the disease. –

Click below for the full article:

Comments are closed.